When further combined with immune checkpoint blockade viaanti-PD-1-loaded nanogels, this strategy converts the immunosuppressivetumor microenvironment into an immunostimulatory niche, enhancingCD8+ T-cell infiltration and promoting long-lasting tumorcontrol in orthotopic HCC models. Here, PDCD1 is linked to hepatocellular carcinoma.